Peter Welch
The Public Record
Peter Francis Welch is an American politician serving as the U.S. Representative for Vermont's at-large congressional district since 2007. A member of the Democratic Party, Welch has focused on issues such as healthcare, agriculture, and climate change during his tenure in Congress. He has been an advocate for policies aimed at supporting Vermont's farmers and addressing the challenges posed by rising healthcare costs.
We have to stop this. And it is why Chairman Pallone and I are moving forward with legislation to protect patients.
Since 1987 it has banned balance billing in the emergency department settings only.
Protecting patients, however, must be put at the forefront of this discussion and I will continue to work with my colleagues on both sides of the aisle to do just that.
I am encouraged that our draft legislation lines up well with the principles the White House has set forth for a solution that could get the President's signature and become law.
But I don't believe it should fairly fall on the shoulders of a consumer who shows up and is absolutely powerless and had nothing to do with creating the mess in the first place.
This is a bright day in the history of the House. We are going to provide relief to people who are innocent. We have the debate about immigration, no question about it. But we are talking about children, infants, in some cases, who were…
Can you think of any policy reason why what you found and what you reported shouldn't be made known to all of the American people so that they can judge for themselves?
This is a great bill, and it has got some of the provisions in the HOMES Act that I have cosponsored with Mr. McKinley.
It is absolutely essential, as you know and I think many of us here know, that rural America is getting written off if we don't have the same high-speed internet that urban America has.
I have indicated a willingness to support just about any revenue measure that will make this happen.
If we are going to stay competitive, if we are going to give our communities and the individuals in our communities the tools that they need to stay competitive domestically and internationally, we have to go big.
I would object to that. Can you think of any policy reason why what you found and what you reported shouldn't be made known to all of the American people so that they can judge for themselves, Mr. Hickey?
So your view is that even taking a random sample to do forensic analysis of the machines themselves was not important...
It is allowed to happen because there are no rules and there is no transparency either to the public to decide whether this is an appropriate use of a technology or not.
I want transparency when there is a claim that it justifies the price increases.
Sanofi increased the price of its drug Lantus by 171 percent from $99 in 2010 to $270 in 2018.
I want four issues. One, R&D spending; 2, stock buybacks; 3, advertising; 4, executive compensation.
The formularies we have now are not done on behalf of the public. They are done for the benefit of the PBMs.
Pharma is claiming that it spends all its money on R&D, but it won't show us the books.





